BRENTWOOD, Tenn. (June 21, 2024) – Ardent Health Partners, LLC (“Ardent Health”) today announced it has publicly filed a registration statement on Form S-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Ardent Health has applied to list its common stock on the New York Stock Exchange under the ticker symbol “ARDT.”
Ardent Health intends to use the net proceeds from the proposed offering to repay certain existing indebtedness and for general corporate purposes.
J.P. Morgan, BofA Securities and Morgan Stanley will act as lead book-running managers for the proposed offering. Stephens Inc., Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, and Mizuho will also act as bookrunners for the proposed offering. Capital One Securities and Loop Capital Markets will act as co-managers for the proposed offering.
The proposed offering will be made only by means of a prospectus, which forms a part of the Registration Statement. Once available, copies of the Registration Statement and preliminary prospectus included therein relating to this proposed offering may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the prospectus, when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmorganchase.com; BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC, 28255-0001, Attn: Prospectus Department, by telephone at 800-294-1322 or by email at dg.prospectus_requests@bofa.com; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.
The Registration Statement relating to the proposed offering has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
About Ardent Health
Ardent Health is a leading provider of healthcare in growing midsize urban communities across the country. With a focus on people and investments in innovative services and technologies, Ardent Health is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent Health delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 providers across six states.
Media Relations:
Rebecca Kirkham
Ardent Health
rebecca.kirkham@ardenthealth.com
Investor Relations:
Stefan Neely
Vallum Advisors